# clm_C48050D45C2E

subject: Amgen (/record/amgen.md)  
predicate: total_equity  
value: 7,656,000,000 United States dollar  
valid_from: 2023-09-30  
valid_to: 2023-12-31  
published: 2023-10-31  
recorded: 2026-11-08  
confidence: 0.95  
status: superseded  
assertable: true  
superseded_by: clm_E5BB4CC8EC5C  
last_updated: 2026-11-08  
cite: AsOf. "Amgen total equity: 7,656,000,000 United States dollar", as of 2023-09-30 (until 2023-12-31). Claim clm_C48050D45C2E, https://asof.is/claim/clm_C48050D45C2E, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/318154/000031815423000064/0000318154-23-000064-index.htm.  
checked: 2026-11-08 · parsed from the SEC filing  
parsed from: us-gaap:StockholdersEquity in 10-Q Q3 FY2023, filed 2023-10-31  

## Sources

- https://www.sec.gov/Archives/edgar/data/318154/000031815423000064/0000318154-23-000064-index.htm (primary, SEC EDGAR 10-Q Q3 FY2023, published 2023-10-31)

## Supersedes

- [Amgen](/record/amgen.md) | total_equity | 6,781,000,000 United States dollar | valid 2023-06-30 to 2023-09-30 | conf 0.95 | superseded | superseded_by [clm_C48050D45C2E](/claim/clm_C48050D45C2E.md) | [clm_3DDAC5296A48](/claim/clm_3DDAC5296A48.md)

---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.